Your session is about to expire
← Back to Search
Radiosurgery vs Whole Brain Radiation for Brain Metastasis
Study Summary
This trial compares stereotactic radiosurgery with whole brain radiation therapy to see how well they work in treating patients with non-melanoma cancer that has recently spread from the first location to the brain.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 2 trial • 32 Patients • NCT01573702Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My blood clotting levels are normal, and I can stop blood thinners for radiosurgery.I have not had surgery to remove cancer from my brain.I have between 4 and 15 lesions, but may have up to 20 at treatment time.My cancer is confirmed to be spreading, based on a tissue sample.I have 3 to 15, possibly up to 20, brain tumors visible on a recent MRI.I do not have cancer spread to the lining of my brain and spinal cord.I have not had whole brain radiation or preventive brain radiation, but I may have had targeted radiation for up to 3 brain metastases.I am 18 years old or older.All my cancer spots can be treated with focused radiation because they are small enough.My liver, kidney, and blood tests are within normal ranges.I am currently receiving other cancer treatments as decided by my doctor.I do not have melanoma, small cell carcinoma, lymphoma/leukemia, or germ cell cancer.
- Group 1: Arm I (SRS)
- Group 2: Arm II (WBRT)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are patients currently being recruited for this trial?
"According to the clinicaltrials.gov listing, this study has wrapped up recruitment as of August 18th, 2022. The trial was first posted on 8/2/2012. Although this specific study is not enrolling patients, there are 2844 other trials with open enrollment at this time."
Has Stereotactic Radiosurgery undergone rigorous testing by the FDA?
"There is a fair amount of data attesting to the safety of Stereotactic Radiosurgery, so it received a score of 3."
What are the aims of this research?
"This trial will aim to observe the proportion of patients that experience neurocognitive decline over a 4 month period. Additionally, this study will secondary track the time to neurocognitive decline (as measured by HVLT-R score), cumulative incidence of local failure, and cumulative incidence of neurocognitive decline."
Share this study with friends
Copy Link
Messenger